Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Asset Writedowns and Impairment (2019)

Updated

Emmaus Life Sciences (EMMA) recorded Asset Writedowns and Impairment of -$9,000 in Q4 2019.

Analysis

Emmaus Life Sciences (EMMA) Asset Writedowns and Impairment (2019) Analysis & Trends

For FY2019, Emmaus Life Sciences reported Asset Writedowns and Impairment of $515,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.92 Bn 1,102.51 Bn 19.71 Bn
2 Johnson & Johnson 634.72 Bn 554.59 Bn 17.30 Bn
3 AbbVie 506.31 Bn 479.42 Bn 12.70 Bn
4 Merck 357.83 Bn 312.21 Bn 12.21 Bn
5 Novartis Ag 291.64 Bn 255.63 Bn 11.24 Bn
6 Astrazeneca 265.27 Bn 238.96 Bn 12.86 Bn
7 Amgen 238.30 Bn 193.70 Bn 7.24 Bn
8 Gilead Sciences 195.34 Bn 169.53 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -9,000.00
API Access

Emmaus Life Sciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EMMA&period=max&api_key=YOUR_API_KEY